We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

82 hedge funds and large institutions have $2.64B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more call options, than puts

Call options by funds: $11.6M | Put options by funds: $2.99M

118% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 17

93% more capital invested

Capital invested by funds: $1.37B → $2.64B (+$1.27B)

32% more funds holding

Funds holding: 62 → 82 (+20)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

Holders
82
Holders Change
+20
Holders Change %
+32.26%
% of All Funds
1.43%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
37
Increased
18
Reduced
18
Closed
17
Calls
$11.6M
Puts
$2.99M
Net Calls
+$8.61M
Net Calls Change
+$8.61M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$53.3M
2
BlackRock
BlackRock
New York
+$22.3M
3
Alkeon Capital Management
Alkeon Capital Management
New York
+$12.8M
4
State Street
State Street
Massachusetts
+$5.4M
5
Northern Trust
Northern Trust
Illinois
+$4.44M

Top Sellers

Rank Fund Capital Flow
1
ABG
Ally Bridge Group
New York
-$15.1M
2
SFM
Sphera Funds Management
Israel
-$12.9M
3
AG
Artal Group
Luxembourg
-$7.16M
4
Citadel Advisors
Citadel Advisors
Florida
-$6.79M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$6.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCI
1
Bain Capital Investors
Massachusetts
$1.55B – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$226M +$53.3M +3,724,661 +73%
PA
3
Perceptive Advisors
New York
$119M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$90.3M +$4.25M +296,575 +9%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$85.2M -$1.04M -72,477 -2%
BlackRock
6
BlackRock
New York
$68M +$22.3M +1,554,987 +142%
Alkeon Capital Management
7
Alkeon Capital Management
New York
$67.8M +$12.8M +896,435 +51%
RCM
8
RA Capital Management
Massachusetts
$56.4M – – –
AG
9
Artal Group
Luxembourg
$51.2M -$7.16M -500,000 -20%
Federated Hermes
10
Federated Hermes
Pennsylvania
$50M – – –
State Street
11
State Street
Massachusetts
$33.5M +$5.4M +377,383 +40%
RSCM
12
Rock Springs Capital Management
Maryland
$26.1M +$170K +11,845 +1%
Alyeska Investment Group
13
Alyeska Investment Group
Illinois
$21.1M -$2.69M -188,091 -19%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$19.3M +$4.42M +308,636 +70%
Citadel Advisors
15
Citadel Advisors
Florida
$19.3M -$6.79M -474,564 -39%
BC
16
Boxer Capital
California
$18.3M – – –
ABG
17
Ally Bridge Group
New York
$17.3M -$15.1M -1,052,920 -61%
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$12.8M -$1.43M -100,000 -17%
RI
19
RTW Investments
New York
$12.8M – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$9.8M -$6.42M -448,297 -54%
Northern Trust
21
Northern Trust
Illinois
$9.73M +$4.44M +310,180 +446%
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$9.44M +$1.03M +71,850 +24%
Charles Schwab
23
Charles Schwab
California
$6.44M +$1.14M +79,823 +46%
AAA
24
Affinity Asset Advisors
New York
$5.12M -$1M -70,000 -26%
AA
25
ALPS Advisors
Colorado
$4.28M +$2.39M +166,983 New
1
2 3 4

CERE Hedge Fund Activity: Q2 2021 in Review

82 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q2 2021, worth a combined $2.64B — up 93% from $1.37B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new CERE positions and 17 closed out — a net gain of 20 holders — while 18 added to existing stakes and 18 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $53.3M. The largest seller was Ally Bridge Group, cutting an estimated $15.1M.

  • 82 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q2 2021, up from 62 in Q1 2021.
  • Funds reported $2.64B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q2 2021, up 93% quarter-over-quarter.
  • 37 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q2 2021 and 17 closed out, a net change of +20 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q2 2021 was Fidelity Investments, an estimated $53.3M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q2 2021 was Ally Bridge Group, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2021.